Nextmune Acquires VetBiotek
December 22, 2023
Nextmune, a global specialty animal-health company, acquired VetBiotek, a developer of veterinary dermatology topical formulations including MicroSilver BG and Ceramide III products. The acquisition expands Nextmune’s dermatology portfolio and aims to improve production, packaging, distribution and access of VetBiotek’s products to veterinary clinics and distributors.
- Buyers
- Nextmune
- Targets
- VetBiotek
- Industry
- Veterinary
- Location
- United States
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.